102
Participants
Start Date
October 31, 2011
Primary Completion Date
February 28, 2013
Study Completion Date
June 30, 2013
Trivalent inactivated influenza vaccine
Inactivated trivalent influenza virus vaccine (Sanofi Pasteur Fluzone® High Dose \[60 mcg x 3 strains\]), as a single intramuscular dose. 80 and up to 100 subjects. Subjects enrolling between October 2011 and February 2012 will receive the 2011-2012 vaccine and subjects enrolling after July 2012 will receive the 2012-2013 vaccine.
Trivalent inactivated influenza vaccine
Inactivated trivalent influenza virus vaccine (Sanofi Pasteur Fluzone® \[15 mcg x 3 strains\]), as a single intramuscular dose. 80 and up to 100 subjects. Subjects enrolling between October 2011 and February 2012 will receive the 2011-2012 vaccine and subjects enrolling after July 2012 will receive the 2012-2013 vaccine.
University of Iowa - Vaccine Research & Education Unit, Iowa City
National Institute of Allergy and Infectious Diseases (NIAID)
NIH